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Introduction
The heptaene macrolide amphotericin B (1a) (Figure 1 ) is a medically important antifungal agent that is produced by Streptomyces nodosus in combination with the tetraene amphotericin A (1b). The antifungal activity of polyenes results from specific interactions with ergosterol, the predominant sterol lipid in fungal membranes.
Polyene-sterol complexes associate to form transmembrane channels that allow unregulated loss of ions and small molecules causing cell death [1] . Amphotericin B has very high activity and is the most effective drug for the treatment of life-threatening systemic fungal infections [2] , and resistance still has not emerged as a serious problem even after more than forty years of regular clinical use.
However, amphotericin B does have severe side-effects that include nephrotoxicity, cardiotoxicity and neurotoxicity, due to low watersolubility and interactions with cholesterol in mammalian cell membranes [3] . As the incidence of life-threatening fungal infections is increasing [4] , there is an urgent need to develop effective new polyene-based antibiotics with reduced toxicity.
Numerous amphotericin analogues have been made by chemical modification of the carboxyl and amino groups [5, 6] . Some of these analogues show improved antifungal specificity, particularly amphotericin B methyl ester. This indicates that more extensive structural alterations could further improve the therapeutic index.
However, it has proved difficult to chemically modify the macrolactone ring. An ability to understand and manipulate the biosynthetic pathway would enable production of large numbers of new analogues with alterations on the macrolactone and the sugar, any of which may prove to be a clinically important alternative to the toxic amphotericin B.
The biosynthesis of the amphotericins has been investigated by feeding experiments with 13 C-labelled precursors [7] and the biosynthetic gene cluster has been characterised [8] . A sluggish enoyl reductase (ER5) is believed responsible for the co-formation of amphotericins A and B (1b, 1a). The macrolactone core (1i, 1j) is assembled from acetate and propionate units by a large modular polyketide synthase encoded within the gene cluster, as are enzymes that assemble the mycosamine sugar from GDP-D-mannose, and the glycosyl transferase to attach the sugar to the ring. The cluster also contains genes for two cytochrome P450 monooxygenases that are thought responsible for hydroxylation at C-8 and oxidation of the C-16 methyl branch to a carboxyl group. Techniques have been developed for replacement of S. nodosus genes to allow the engineered biosynthesis of amphotericin analogues [8] . Here, these developments are exploited to disrupt genes involved in the late steps of amphotericin biosynthesis. The results provide the first insights into the order in which these tailoring modifications occur and also generate previously unavailable analogues of amphotericins for therapeutic testing.
Results

Disruption of the amphDIII gene
A 2091 base-pair region of the amphotericin cluster (nucleotides 3474 -5565 [8] ) containing the amphDIII gene was amplified by PCR using oligonucleotides designed to introduce unique Bam HI and Pst I sites at opposite ends of the product. These sites were used to clone the amplified DNA into pUC118. The resulting plasmid was digested with Bgl II, which cuts a single site approximately in the centre of the amphDIII gene. The cohesive ends were repaired with T4 DNA polymerase and ligated to create a frameshift mutation. The removal of the Bgl II site was verified by restriction analysis. The Bam HI-Pst I fragment was cloned into KC515 and recombinant phage were identified by PCR using primers specific for the insert. The KC515-amphDIII phage was propagated on S. nodosus and three thiostrepton-resistant lysogens were isolated and purified. One of the lysogens was cultured in the absence of thiostrepton to allow prophage excision and gene replacement to occur. The mycelial cells were converted to protoplasts to generate single cell units. After protoplast regeneration, single colonies were tested for thiostrepton sensitivity to identify clones in which a second cross-over event had excised the prophage. Nineteen thiostrepton-sensitive revertants were obtained from 208 clones.
Genomic DNA was isolated from these revertants and the amphDIII region was amplified by PCR and subjected to restriction analysis.
Two of the revertants gave PCR products which lacked a Bgl II site and were identified as amphDIII mutants. Figure 2 shows restriction analysis of the amphDIII region PCR products amplified from S. nodosus ATCC14899 and one of the replacement mutants.
Analysis of polyenes made by amphDIII mutant
The amphDIII mutant was grown on fructose-dextrin-soybean medium [7] , and was shown by UV spectrophotometry to produce tetraenes (50-250 mg/L culture broth), and lower levels of heptaenes, predominantly in the sedimentable mycelial fraction of the cultures.
This mycelial sediment was extracted with methanol and the tetraenes were partially purified by selective precipitation (removing some heptaene and more polar polyene products). Analysis by ESMS indicated that the major products present were 8-deoxyamphoteronolides along with some amphoteronolides. Figure 3 shows spectra obtained with a sample enriched in 8-deoxyamphoteronolide A (1f) with some amphoteronolide A.
The partially purified 8-deoxyamphoteronolides were converted to methyl esters (1g) and (1h) and a fraction containing mainly tetraene products further purified by normal phase HPLC, from which two tetraenes were isolated, both with the expected molecular weight (778.4). Analysis of one of these components by proton, carbon and proton-proton 2D NMR gave spectra consistent with methyl 8-deoxyamphoteronolide A (1h) ( Figure 4A ) [9] . Preliminary NMR analysis of the second component gave spectra consistent with either methyl 37-epi-8-deoxyamphoteronolide B or methyl 36-epi-8-deoxyamphoteronolide B ( Figure 4B ). This assignment is based upon a large upfield shift of H-37 in the proton and 2D NMR spectra from 5. nodosus. This observation is consistent with previous findings that a positive charge on the amino group of mycosamine is essential for significant antifungal activity [5] .
Disruption of amphL gene
The amphotericin cluster contains two cytochrome P450 genes, amphL and amphN. The AmphN protein shows a high degree of sequence identity with the NysN, PimG and CanC proteins that are thought to function in formation of exocyclic carboxyl groups in nystatin, pimaricin and candicidin [15] . The AmphL protein is homologous to the NysL P450 which is thought to introduce the C-10 hydroxyl group of nystatin [16] and to PimD which introduces the epoxide in the polyol chain of pimaricin. Aparicio et al. disrupted pimD to produce a novel pimaricin, de-epoxypimaricin [17] . These 
Analysis of polyenes made by amphL mutant
The amphL mutant produced heptaene and tetraenes that were found predominantly in the mycelial fraction of the culture. The 
Discussion
Manipulation of biosynthetic genes is yielding novel polyene macrolides. Aparicio and co-workers have produced de-epoxypimaricin [17] and Zotchev et al. [18] have produced a hexaene derivative of nystatin as well as trace levels of a heptaene analogue. This study describes the first amphotericin analogues that have been generated by engineered biosynthesis, and provides the first insights into the order in which the late stages of amphotericin biosynthesis occur.
The amphDIII mutant produced 8-deoxyamphoteronolides as major It is important to mention preliminary data that suggests that this sequence of events may not be obligatory in all circumstances.
We have recently disrupted the amphN gene after numerous unsuccessful attempts (M. Carmody and P. Caffrey, unpublished data). Although purification and chemical analyses have not yet been carried out, the amphN mutant produces low yields of heptaenes and tetraenes that retain antifungal activity. This raises the possibility that glycosylation can occur in the absence of exocyclic carboxyl group formation. Gene disruption studies may not be sufficient for determining whether these two steps occur in a preferred order. On the other hand, this approach promises to yield several amphotericin analogues rather than the few that could be generated from a single linear pathway. In addition, the amphDI gene could be subjected to error-prone PCR or DNA shuffling to develop glycosyltransferases that can recognise the polyene aglycone and other dTDP-glucose derived amino sugars.
Successfully redesigned glycosyltransferases could be detected by screening for restored antifungal activity.
The detection of epimeric 8-deoxyamphoteronolides is interesting and suggests that the amphotericin system may be useful for determining how PKS modules determine alkyl stereochemistry in nascent chains.
The amphL mutant produced 8-deoxyamphotericins although the yields were significantly lower than the yields of 8-deoxyamphoteronolides from the amphDIII mutant. This may reflect regulatory phenomena or feedback mechanisms that are not yet understood. The 8-deoxyamphotericins were less soluble than amphotericin B. However, they retained activity and could be tested as antifungal drugs. Polyenes are also active against Leishmania parasites, enveloped viruses, prion proteins [6] , and hepatocellular tumours [19] . These additional biological activities appear to result from interactions of the polyene with sterol-rich membranes.
Some of the amphotericin analogues could be useful for some or all of these potential medical applications.
Significance
These results show that formation of the exocyclic carboxyl group of amphotericin B can occur prior to glycosylation with mycosamine. The second hydroxylation, at C-8, appears to be inefficient in the absence of prior glycosylation. One possible order of the macrolactone tailoring steps is: exocyclic carboxyl group formation, mycosaminylation and C-8 hydroxylation.
The amphDIII mutant produced 8-deoxyamphoteronolides that had little antifungal activity. However, this mutant strain can now be 
Experimental Procedures
Genetic procedures
PCRs were carried out with Taq or Vent DNA polymerases as described [20] using a Perkin Elmer GeneAmp 2400 thermocycler. The oligonucleotide primers were synthesised by GenoSys, Cambridge, UK.
The oligonucleotides used to amplify the amphDIII region were 5' CCGAGGATCCGCACCAGATGCAAAACGAC 3' and 5' TAAACTGCAGGACAGCACGCTGCCGGTGTTG 3'. The oligonucleotides used to detect the amphL phage were 5' GCGGGGATCCTAGCTGAAGCAGCTGCTGCAC 3' and 5' CAGGTCGACATGGGTGGCAAC 3'
Methods for DNA manipulation were as described by [20] .
Escherichia coli strain XL1-Blue MR was used as a host for propagation of plasmids. Plasmid DNA was isolated using the alkaline-SDS procedure. Restriction enzyme digestions and ligations were carried out using standard procedures. Competent E. coli cells for transformation were prepared by the calcium chloride method.
Methods for preparation of streptomycete spores and protoplasts were those described by Hopwood et al. [21] . Streptomyces lividans 66 (John Innes strain 1326) was used for propagation of phage KC515 [22] . Phage KC515 DNA was isolated using the small-scale method [21] . DNA fragments ligated to KC515 DNA were introduced into S.
lividans 66 protoplasts by transfection [21] . Recombinant phage were identified by PCR using primers specific for the cloned inserts.
S. nodosus ATCC 14899 was used as the parent strain for gene disruptions. To obtain lysogens, recombinant phage were plated on S.
nodosus spores to give near confluent lysis. After overnight incubation, plates were overlayed with soft nutrient agar containing thiostrepton (50 g/mL). Thiostrepton-resistant lysogens resulting from integration of the phage were streaked on tryptone soya (TS) agar containing thiostrepton. Lysogens were cultured in the absence of thiostrepton then protoplasts were allowed to regenerate.
Regenerated protoplasts were toothpicked onto TS agar and TS agar containing thiostrepton to identify thiostrepton sensitive revertants.
Labelling of probes with digoxigenin-dUTP and detection of hybridising DNA were carried out using a Boehringer Mannheim DIG DNA labelling and detection kit. For Southern hybridisation, DNA fragments were transferred to nylon membranes by capillary transfer [20] .
Production and analysis of polyenes
For polyene production, S. nodosus was grown on fructosedextrin-soybean medium [7] . 100 l samples of culture (containing 
Chemical methods
UV spectrophotometry was performed using a Hewlett Packard 8452A diode array spectrophotometer using 1 cm path length.
Electrospray mass spectrometry was performed on a Micromass Quattro LC. Nuclear Magnetic Resonance (NMR) spectroscopy was performed on a Bruker DRX 400 spectrometer. HPLC was performed on a Shimadzu LC-4A
with a UV detector.
For preparative-scale production and purification of polyenes, a glycerol deep (1 mL) was added to GYE media (100 mL; 10 g/L yeast extract; 10 g/L glucose, pH 7) and shaken in an orbital incubator shaker (New Brunswick Series 25) at 28C for 48 h at 160 rpm.
Portions ( 
